Intravenous etidronate in the management of malignant hypercalcemia
- 1 March 1985
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 145 (3) , 449-452
- https://doi.org/10.1001/archinte.145.3.449
Abstract
Research from JAMA Internal Medicine — Intravenous Etidronate in the Management of Malignant HypercalcemiaThis publication has 6 references indexed in Scilit:
- COMPARISON OF INTRAVENOUS (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE AND VOLUME REPLETION IN TUMOUR-INDUCED HYPERCALCAEMIAThe Lancet, 1983
- Comparison of two parenteral diphosphonates in hypercalcemia of malignancyThe American Journal of Medicine, 1982
- Long-Term Effects of Dichloromethylene Diphosphonate (Cl2 DP) on skeletal Lesions in Multiple MyelomaMetabolic Bone Disease and Related Research, 1982
- Hypercalcemia of Malignancy: Treatment with Intravenous Dichloromethylene DiphosphonateAnnals of Internal Medicine, 1981
- Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases.Journal of Clinical Investigation, 1980
- Direct Resorption of Bone by Human MonocytesScience, 1977